A previous study has shown that the lncRNA SLC26A4-AS1 promotes NPTX1 transcriptional activity by recruiting NFKB1, thereby exerting antiangiogenic effects in glioma cells [22]. This evidence concerns the gene SLC26A4 and central nervous system cancer.